Lena Shaghlil

Dr. Lena Shaghlil

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
NANafisah Al-Rifai
Nafisah Al-Rifai
AAAnas Alshishani
Anas Alshishani
FDFouad Darras
Fouad Darras
OTOla Taha
Ola Taha
SAShereen Abu-Jalloud
Shereen Abu-Jalloud
YAYousef Al-Ebini
Yousef Al-Ebini
Given that impurities may affect the quality and safety of drug products, impurity identification and profiling is an integral part of drug quality control and is particularly important for newly developed medications such as solriamfetol, which is used to treat excessive daytime sleepiness. Although the high-performance liquid chromatography analysis of commercial solriamfetol has revealed the presence of several impurities, their synthesis, structure elucidation, and chromatographic determination have not been reported yet. To bridge this gap, we herein identified, synthesized, and isolated eight process-related solriamfetol impurities, characterized them using spectroscopic and chromatographic techniques, and proposed plausible mechanisms of their formation. Moreover, we developed and validated a prompt impurity analysis method based on ultrahigh-performance liquid chromatography with UV detection, revealing that its selectivity, linearity, accuracy, precision, and quantitation limit meet the acceptance criteria of method validation stipulated by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use. Thus, the developed method was concluded to be suitable for the routine analysis of solriamfetol substances.

8 July 2023 in Microchemical Journal
Verified
Journal Article
Closed access
ASAsmaa Abu Sa'ALeek
Asmaa Abu Sa'ALeek
AAAnas Alshishani
Anas Alshishani
LSLena Shaghlil
Lena Shaghlil
JAJameel S. Aljariri Alhesan
Jameel S. Aljariri Alhesan
YAYousef Al-Ebini
Yousef Al-Ebini

22 July 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LSLena Shaghlil
Lena Shaghlil
YAYousef Al-ebini
Yousef Al-ebini
MSMahmoud J. Al Shawabkeh
Mahmoud J. Al Shawabkeh
FAFatmawati Adam
Fatmawati Adam
Kuldeep SAXENAKuldeep SAXENA
Kuldeep SAXENA
WAN SHARUZI WAN HARUNWAN SHARUZI WAN HARUN
WAN SHARUZI WAN HARUN
Nose-to-brain (N2B) delivery is a practical, non-invasive strategy for CNS targeting that can increase brain exposure while limiting systemic exposure. This review integrates three milestones in N2B delivery, formulations, devices, and quantitative evaluation strategies, to define design rules for effective olfactory/trigeminal deposition and enhance translational relevance. Formulations emphasize mucoadhesive systems, nanoparticle carriers (polymeric, lipid-based, and hybrid), nano-emulsions, and stimuli-responsive “smart” gels that prolong nasal residence. Regarding device advancements, the review covers conventional nasal sprays optimized for plume geometry and droplet size. Furthermore, it examines breath-actuated metered sprays, which promote soft palate closure to route aerosols to superior regions, and vibrating mesh nebulizers capable of low-velocity mists for improved upper cavity deposition. Quantitative evaluation is discussed, including 3D-printed, anatomy-accurate nasal casts, high-speed spray diagnostics, and computational fluid dynamics (CFD). This review further links formulation and device parameters to regional deposition. Available clinical and animal data illustrate the feasibility of these approaches, safety considerations, and user-technique dependencies, while highlighting the need for standardized, anatomy-aware testing protocols. Together, these developments suggest that co-designed formulation device platforms, validated by cast/CFD metrics and supported by clinical imaging or pharmacokinetic data, can support N2B product development toward consistent, patient-relevant outcomes.

6 August 2025 in Bioprinting
Verified
Journal Article
Closed access
WAN SHARUZI WAN HARUNWAN SHARUZI WAN HARUN
WAN SHARUZI WAN HARUN
JJJuliana Jumadi
Juliana Jumadi
LSLena Shaghlil
Lena Shaghlil
KKKumaran Kadirgama
Kumaran Kadirgama
SSSafian Sharif
Safian Sharif
TFTsumori Fujio
Tsumori Fujio